Found: 1
Select item for more details and to access through your institution.
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies
- Published in:
- Annals of Hematology, 2015, v. 94, n. 1, p. 23, doi. 10.1007/s00277-014-2177-y
- By:
- Publication type:
- Article